Literature DB >> 3037765

Comparison by the neutralisation assay of pairs of non-cytopathogenic and cytopathogenic strains of bovine virus diarrhoea virus isolated from cases of mucosal disease.

C J Howard, J Brownlie, M C Clarke.   

Abstract

Neutralising antibody to non-cytopathogenic and cytopathogenic strains of bovine virus diarrhoea virus (BVDV) was assayed in a microtitre test in which cultures of calf testis cells were stained by the immunoperoxidase method to detect viral replication. Fourteen BVDV strains were compared in cross neutralisation tests with antisera prepared in gnotobiotic calves. Ten of the strains comprised five pairs of non-cytopathogenic and cytopathogenic BVDV. Each pair was isolated from an animal with mucosal disease. All five animals were from five separate outbreaks of the disease. Each pair of strains from the same outbreak was found to be antigenically indistinguishable. In contrast, when the coefficient of antigenic similarity was calculated 11 of 45 comparisons between the pairs and 46 of 91 comparisons between all 14 viruses gave R values that distinguished strains. The observations suggest that an antigenic spectrum within a single related group exists for BVDV strains, rather than distinct serotypes. The findings are also consistent with the suggestion that cytopathogenic strains from natural outbreaks of mucosal disease arise by mutation from non-cytopathogenic virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037765     DOI: 10.1016/0378-1135(87)90067-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  16 in total

1.  Bovine viral diarrhea virus strain- and cell type-specific inhibition of type I interferon pathways.

Authors:  Amanda Gibson; Jenny Larsson; Michaela Bateman; Joe Brownlie; Dirk Werling
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  The application of monoclonal antibody panels to characterize pestivirus isolates from ruminants in Great Britain.

Authors:  S Edwards; J J Sands; J W Harkness
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Monoclonal antibodies with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. Brief report.

Authors:  S Bolin; V Moennig; N E Kelso Gourley; J Ridpath
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.

Authors:  R W Fulton; J T Saliki; L J Burge; J M d'Offay; S R Bolin; R K Maes; J C Baker; M L Frey
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Variation in the intracellular polypeptide profiles from different isolates of bovine virus diarrhoea virus.

Authors:  D H Pocock; C J Howard; M C Clarke; J Brownlie
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Monoclonal antibodies to the p80/125 gp53 proteins of bovine viral diarrhea virus: their potential use as diagnostic reagents.

Authors:  D Deregt; S A Masri; H J Cho; H Bielefeldt Ohmann
Journal:  Can J Vet Res       Date:  1990-06       Impact factor: 1.310

7.  Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysis.

Authors:  S Vilcek; A J Herring; J A Herring; P F Nettleton; J P Lowings; D J Paton
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 8.  Bovine viral diarrhea virus: biotypes and disease.

Authors:  D Deregt; K G Loewen
Journal:  Can Vet J       Date:  1995-06       Impact factor: 1.008

9.  Antigenic differences between a field isolate and vaccine strains of bovine viral diarrhea virus.

Authors:  J R Reddy; W Xue; S Rivera; H C Minocha
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Monoclonal antibody analyses of cytopathic and noncytopathic viruses from fatal bovine viral diarrhea virus infections.

Authors:  W V Corapi; R O Donis; E J Dubovi
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.